Scarica l'app Stockscreener
18.61
14.03%
2.29
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ADPT Giù?
Forum
Previsione
Precedente Chiudi:
$16.32
Aprire:
$16.28
Volume 24 ore:
5.06M
Relative Volume:
2.60
Capitalizzazione di mercato:
$2.84B
Reddito:
$205.22M
Utile/perdita netta:
$-121.24M
Rapporto P/E:
-22.86
EPS:
-0.8141
Flusso di cassa netto:
$-82.81M
1 W Prestazione:
+31.99%
1M Prestazione:
+7.26%
6M Prestazione:
+104.73%
1 anno Prestazione:
+325.86%
Intervallo 1D:
$16.18
$18.98
Intervallo di 1 settimana:
$13.28
$18.98
Portata 52W:
$4.29
$18.98
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
Nome
Adaptive Biotechnologies Corp
Settore
Industria
Telefono
206-659-0067
Indirizzo
1165 EASTLAKE AVE E, SEATTLE, WA
Confronta ADPT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
18.61 | 2.49B | 205.22M | -121.24M | -82.81M | -0.8141 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-30 | Iniziato | Guggenheim | Buy |
| 2025-06-18 | Iniziato | Craig Hallum | Buy |
| 2025-03-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-12-21 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Underperform |
| 2022-06-03 | Iniziato | Piper Sandler | Neutral |
| 2022-02-16 | Reiterato | BTIG Research | Buy |
| 2022-02-16 | Reiterato | BofA Securities | Buy |
| 2022-02-16 | Reiterato | Goldman | Neutral |
| 2022-02-16 | Reiterato | JP Morgan | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-03-03 | Downgrade | Goldman | Buy → Neutral |
| 2020-10-08 | Ripresa | BTIG Research | Buy |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-06-03 | Iniziato | Goldman | Buy |
| 2019-07-23 | Iniziato | BTIG Research | Buy |
| 2019-07-22 | Iniziato | BofA/Merrill | Buy |
| 2019-07-22 | Iniziato | Cowen | Outperform |
| 2019-07-22 | Iniziato | Goldman | Neutral |
| 2019-07-22 | Iniziato | Guggenheim | Buy |
| 2019-07-22 | Iniziato | William Blair | Outperform |
Mostra tutto
Adaptive Biotechnologies Corp Borsa (ADPT) Ultime notizie
Adaptive Biotechnologies (ADPT) Hits 3-Year High. Here's Why - Finviz
Adaptive Biotechnologies (ADPT) Hits 3-Year High. Here’s Why - Insider Monkey
ADPT Stock Sees Significant 11.3% Increase - GuruFocus
Adaptive Biotechnologies stock hits 52-week high at $17.89 - Investing.com
Check out these key findings about Adaptive Biotechnologies Corp (ADPT) - Setenews
Why Adaptive Biotechnologies Corporation (1HM) stock stays resilientWeekly Investment Report & Precise Swing Trade Entry Alerts - newser.com
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Adaptive Biotechnologies (NASDAQ:ADPT) Trading Up 6.3%Should You Buy? - MarketBeat
Is Adaptive Biotechnologies Corporation (1HM) stock a top hedge fund pickAnalyst Upgrade & Weekly High Return Forecasts - newser.com
How strong is Adaptive Biotechnologies Corporation (1HM) stock earnings growthOil Prices & Consistent Growth Equity Picks - newser.com
Is Adaptive Biotechnologies Corporation (1HM) stock safe for risk averse investorsMarket Trend Report & Risk Adjusted Buy/Sell Alerts - newser.com
Adaptive Biotechnologies at Jefferies: Strategic Growth Insights - Investing.com
Can technical indicators confirm Adaptive Biotechnologies Corporation’s reversalQuarterly Profit Summary & Short-Term Trading Alerts - newser.com
Adaptive Biotechnologies CFO Piskel sells $3343 in shares - Investing.com
Continued Momentum Lifted Adaptive Biotechnologies Corporation (ADPT) in Q3 - Yahoo Finance
Will Adaptive Biotechnologies Corporation (1HM) stock sustain uptrend momentumQuarterly Profit Review & Real-Time Stock Entry Alerts - newser.com
Evaluating Adaptive Biotechnologies Corporation with trendline analysisWeekly Trade Report & Weekly Breakout Opportunity Watchlist - newser.com
Using Ichimoku Cloud for Adaptive Biotechnologies Corporation technicals2025 Historical Comparison & AI Enhanced Trading Signals - newser.com
Adaptive Biotechnologies CEO Robins sells $1.3m in shares By Investing.com - Investing.com Nigeria
Chad Robins Sells 89,265 Shares of Adaptive Biotechnologies Corp - GuruFocus
Adaptive Biotechnologies CEO Robins sells $1.3m in shares - Investing.com India
Adaptive Biotechnologies Executives Sell Shares Under Trading Plan - TradingView
Adaptive Biotechnologies (ADPT): Morgan Stanley Raises Price Tar - GuruFocus
What catalysts could drive Adaptive Biotechnologies Corporation stock higherPortfolio Update Report & Weekly Hot Stock Watchlists - newser.com
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q3 2025 Earnings Call Transcript - Insider Monkey
Adaptive Biotechnologies (ADPT) Surges to First Profit and Lifts Guidance—Has the Investment Case Evolved? - Yahoo Finance
Does Adaptive Biotechnologies Corporation fit your quant trading model2025 Technical Overview & Stepwise Swing Trade Plans - newser.com
Adaptive Biotechnologies Q3 2025 slides: MRD business turns profitable as revenue surges 52% - Investing.com Australia
Adaptive Biotechnologies Q3 2025 slides: MRD business turns profitable as revenue surges 52% By Investing.com - Investing.com South Africa
JP Morgan Raises Price Target for Adaptive Biotechnologies (ADPT) to $20 | ADPT Stock News - GuruFocus
Earnings call transcript: Adaptive Biotechnologies Q3 2025 beats forecasts with EPS and revenue By Investing.com - Investing.com South Africa
Adaptive Biotechnologies (Nasdaq: ADPT) to join Jefferies London, Piper Sandler; webcast - Stock Titan
Earnings call transcript: Adaptive Biotechnologies Q3 2025 beats forecasts with EPS and revenue - Investing.com Philippines
ADPT (Adaptive Biotechnologies) Days Inventory : 43.31 (As of Jun. 2025) - GuruFocus
A Look at Adaptive Biotechnologies Corp (ADPT) Shares in the Recent Past Indicates Growth - setenews.com
Adaptive Biotechnologies Reports Breakout Quarter With Profitable MRD Growth - Finimize
Adaptive Biotechnologies: Q3 Earnings Snapshot - ctinsider.com
Decoding Adaptive Biotechnologies Corp (ADPT): A Strategic SWOT Insight - GuruFocus
Why Adaptive Biotechnologies Corporation stock could benefit from AI revolution2025 Price Targets & Smart Swing Trading Techniques - newser.com
Adaptive Biotechnologies Corp (ADPT) Q3 2025 Earnings Call Highlights: Record Revenue Growth ... By GuruFocus - Investing.com Canada
Adaptive Biotechnologies Q3 2025 Earnings Call Transcript - MarketBeat
Adaptive Biotechnologies Corp (ADPT) Q3 2025 Earnings Call Highlights: Record Revenue Growth ... - Yahoo Finance
Adaptive Biotechnologies (ADPT) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
Adaptive Biotechnologies Corp Azioni (ADPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):